NCT05663580View on ClinicalTrials.gov

Cohort Study of HIV-positive People, Treated With Long Acting Antiretroviral Therapy

RecruitingOBSERVATIONAL
Enrollment

1,500

Participants

Timeline

Start Date

July 17, 2022

Primary Completion Date

July 17, 2024

Study Completion Date

July 17, 2027

Conditions
HIV Infections
Interventions
DRUG

Cabotegravir 600mg/3mL, Rilpivirine 900mg/3mL

Initial administration of two separate intramuscolar injection of cabotegravir 400mg/3mL and rilpivirine 600mg/3mL in opposite gluteal muscles, repeated one month later and then every two months.

Trial Locations (1)

20127

RECRUITING

Ospedale San Raffaele Scientific Institute, Milan

All Listed Sponsors
lead

Castagna Antonella

OTHER